RedHill Biopharma Ltd.
Hedge Funds Holdings
Last updated:
RedHill Biopharma Ltd.‘s stocks are currently a part of 13 hedge funds’ portfolios, which represents 0.49% of the total amount of its stocks outstanding. This makes up a total of 28.23K shares of RedHill Biopharma Ltd.. Compared to the previous quarter, the number fell by -89.33% or -236.25K shares fewer. As for the holding position changes, 7.69% (1) of current hedge fund investors increased the number of shares held, and 200% (26) closed the holdings completely. 13 hedge funds are new holders of RedHill Biopharma Ltd. stock in Q1 2023, it is 100% of total holders.
Hedge funds holding RedHill Biopharma Ltd. (Q2 2018 – Q1 2023)
| Q2 2018 | 30 |
|---|---|
| Q3 2018 | 40 |
| Q4 2018 | 36 |
| Q1 2019 | 35 |
| Q2 2019 | 34 |
| Q3 2019 | 37 |
| Q4 2019 | 43 |
| Q1 2020 | 47 |
| Q2 2020 | 43 |
| Q3 2020 | 54 |
| Q4 2020 | 62 |
| Q1 2021 | 63 |
| Q2 2021 | 52 |
| Q3 2021 | 56 |
| Q4 2021 | 52 |
| Q1 2022 | 44 |
| Q2 2022 | 44 |
| Q3 2022 | 38 |
| Q4 2022 | 39 |
| Q1 2023 | 13 |
Hedge funds changes in RedHill Biopharma Ltd. positions (Q2 2018 – Q1 2023)
| Q2 2018 | 5 | 11 | 4 | 4 | 6 |
|---|---|---|---|---|---|
| Q3 2018 | 14 | 12 | 6 | 4 | 4 |
| Q4 2018 | 7 | 14 | 6 | 11 | -2 |
| Q1 2019 | 3 | 8 | 12 | 4 | 8 |
| Q2 2019 | 4 | 4 | 11 | 5 | 10 |
| Q3 2019 | 7 | 9 | 9 | 3 | 9 |
| Q4 2019 | 11 | 9 | 8 | 5 | 10 |
| Q1 2020 | 10 | 17 | 8 | 3 | 9 |
| Q2 2020 | 5 | 19 | 9 | 10 | 0 |
| Q3 2020 | 17 | 21 | 7 | 6 | 3 |
| Q4 2020 | 15 | 23 | 12 | 7 | 5 |
| Q1 2021 | 11 | 23 | 18 | 9 | 2 |
| Q2 2021 | 8 | 17 | 14 | 19 | -6 |
| Q3 2021 | 16 | 15 | 14 | 11 | 0 |
| Q4 2021 | 13 | 12 | 19 | 18 | -10 |
| Q1 2022 | 2 | 12 | 15 | 10 | 5 |
| Q2 2022 | 4 | 12 | 14 | 4 | 10 |
| Q3 2022 | 4 | 14 | 8 | 10 | 2 |
| Q4 2022 | 10 | 9 | 10 | 8 | 2 |
| Q1 2023 | 13 | 1 | 0 | 26 | -27 |
Hedge funds changes in RedHill Biopharma Ltd. stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 154,000 | 0 |
|---|---|---|
| Q3 2018 | 169,000 | 0 |
| Q4 2018 | 86,000 | 0 |
| Q1 2019 | 123,000 | 0 |
| Q2 2019 | 72,000 | 0 |
| Q3 2019 | 116,000 | 130,000 |
| Q4 2019 | 50,000 | 75,000 |
| Q1 2020 | 0 | 55,000 |
| Q2 2020 | 852,000 | 683,000 |
| Q3 2020 | 2,417,000 | 2,632,000 |
| Q4 2020 | 1,975,000 | 2,195,000 |
| Q1 2021 | 2,506,000 | 2,976,000 |
| Q2 2021 | 3,561,000 | 2,379,000 |
| Q3 2021 | 3,047,000 | 1,399,000 |
| Q4 2021 | 962,000 | 536,000 |
| Q1 2022 | 326,000 | 207,000 |
| Q2 2022 | 63,000 | 28,000 |
| Q3 2022 | 32,000 | 11,000 |
| Q4 2022 | 11,748 | 1,989 |
| Q1 2023 | 66,000 | 11,000 |